Value Communication Materials

Transforming Evidence into Impactful Value Stories

At RTI-HS, we specialize in developing strategic, evidence-based materials that communicate the value of your product to key stakeholders—payers, providers, policymakers, and patient advocates. In addition to Global Value Dossiers (GVDs) we can develop value communication materials to help you bridge the gap between complex data and actionable insights, ensuring your product’s story resonates across global markets.

How We Can Help You

We combine deep payer insights with structured research to craft materials that are:

  • Scientifically sound
  • Visually engaging
  • Easy to navigate
  • Tailored to stakeholder priorities

Our approach includes:

  • Literature reviews and evidence synthesis
  • Advisory panels and stakeholder interviews
  • Value mapping and landscape assessments
  • Health equity considerations and gap analyses

3D blue bar chart and pie chart on financial reports showing data analytics for value communication

Interactive Communication Toolkits

Designed for field-based teams and affiliates, our toolkits provide customizable slide decks and resources to support payer and stakeholder engagement.

Toolkit Components:

  • Executive summaries with key value messages
  • Disease burden and unmet need overviews
  • Policy and environmental context pre- and post-launch
  • Clinical, economic, and humanistic value summaries
  • Objection handling strategies
  • Section 114-compliant product information (US)
  • Summaries of clinical trials and HEOR studies

Objection Handlers

Objection handlers are for reactive use when your teams are challenged by payers and need to respond quickly, but accurately, with a globally approved answer. They can be developed in collaboration with your affiliates and incorporate payer research to ensure both the questions and answers are relevant and impactful.

Slide Sets

To help you communicate with audiences who may not require the level of detail contained in a GVD, we can develop slide sets to present your information in a clear and concise format. Typical audiences for these slide sets include stakeholders in non-HTA markets and regional and local payers.

Featured Publications

Mayer SE, Layton JB, Praet N, Haynes K, Alam S, Bell EJ, Brown J, Coughlin K, Daniels K, Dea K, DeVries A, Diessner BJ, Djibo DA, Horgan CE, Love SA, Ma Q, McMahill-Walraven CN, Moyneur E, Platt R, Reynolds JS, Selvan M, Yost E, Zhao Y, Ziyadeh NJ, Fuller CC, Gilsenan A. Quantitative bias analysis to assess impact of outcome misclassification in a claims-based COVID-19 vaccine safety study in the US. Presented at the 2025 International Society for Pharmacoepidemiology (ISPE) Annual Meeting; August 26, 2025. Washington, DC.
Yosipovitch G, Reaney M, Eckert L, Nelson L, Clark M, Abbe A, Ardeleanu M, Radin A, Gadkari A. Validation of the peak pruritus numerical rating scale: results from clinical studies of dupilumab in adults with moderate-to-severe atopic dermatitis. Poster presented at the Australasian College of Dermatologists 50th Annual Scientific Meeting; May 2017. Sydney, Australia. [abstract] Australas J Dermatol. 2017 May; 58(S1):106-7. Previously presented at the 2017 American Academy of Dermatology Annual Meeting. doi: 10.1111/ajd.21_12652

Meet Our Experts